NVDA gained a massive 197% since our AI first added it in November - is it time to sell? 🤔Read more

Bayer dismisses antitrust concerns about digital farming

Published 19/09/2017, 13:28
© Reuters. The logo of Bayer AG is pictured at the Bayer Healthcare subgroup production plant in Wuppertal
BAYGN
-
MON
-

MONHEIM, Germany (Reuters) - Bayer (DE:BAYGn) said it was unable to propose the sale of any digital farming assets to allay EU concerns about its planned $66 billion (£48.89 billion) takeover of Monsanto (N:MON).

The European Commission last month started an in-depth investigation into the German group's plan to acquire the U.S. seeds maker.

Among its concerns, the regulator took issue with Bayer's plan to create combined offerings of seeds and pesticides with the help of new digital farming tools, such as connected sensors, software and precision machines.

"I fail to see what kind of a remedy there would be in this space. It's extremely hypothetical in terms of where the overlap actually is," the head of Bayer's Crop Science division, Liam Condon, told Reuters on Tuesday, following a press conference on the business.

"If it's considered that that is an issue and a remedy is required then we have to discuss what the remedy is. I just don't have the imagination what that could be."

Condon said Bayer's approach in digital farming was currently to control plant pests while Monsanto's focus was on improving yields. The entire industry was still years away from a more universal business model, he added.

Bayer has pledged that any future software platform coming from its labs would not per se exclude rivals' seeds and crop protection products.

© Reuters. The logo of Bayer AG is pictured at the Bayer Healthcare subgroup production plant in Wuppertal

Analysts, however, say that many in the industry were working on future business models that will lure farmers with a type of money-back guarantee if a digital farming package, complete with predefined seeds and chemicals, does not yield certain harvest levels.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.